Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0000908937-26-000015
- form_type
- 8-K
- ticker
- SIRI
- cik
- 0000908937
- company_name
- SIRIUS XM HOLDINGS INC.
- filed_at
- 2026-06-01T20:28:55+00:00
- discovered_at
- 2026-06-01T20:30:00.264028+00:00
- generated_at
- 2026-06-01T20:37:58.118438+00:00
- sec_items
- ["5.02", "5.07", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0000908937-26-000015
- json_url
- https://secwatch.observer/filing/0000908937-26-000015.json
- markdown_url
- https://secwatch.observer/filing/0000908937-26-000015.md
- text_url
- https://secwatch.observer/filing/0000908937-26-000015.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/908937/000090893726000015/0000908937-26-000015-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/908937/000090893726000015/siri-20260528.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Source-grounded claims
af2f7abb5eac8713b5ad39df17a3ca26ec3ba932
SIRIUS XM HOLDINGS INC. shareholders approved Election of Class I and Class II Directors at the 2026-05-28 meeting.
Election of Directors The holders of our common stock elected the persons listed below as Class I directors. Votes Cast For Votes Withheld Broker Non-Votes Eddy W. Hartenstein 229,472,971 4,921,855 51,448,019 Kristina M. Salen 231,643,217 2,751,609 51,448,019 Jennifer C. Witz 230,660,585 3,734,241 51,448,019 The holders of our common stock elected the persons listed below as Class II directors. Votes Cast For Votes Withheld Broker Non-Votes Evan D. Malone 230,881,893 3,512,933 51,448,019 Jonelle Procope 210,894,725 23,500,101 51,448,019 Anjali Sud 213,150,753 21,244,073 51,448,019
SEC 8-K Item 5.07
confidence 0.95
SEC evidence
b722d82b548f5432af6cb9d4962a767608ee3db7
SIRIUS XM HOLDINGS INC. shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2026-05-28 meeting.
Item 2 – Advisory Vote on Named Executive Officer Compensation The holders of our common stock approved, on a non-binding advisory basis, the compensation paid to our named executive officers. Votes Cast For Votes Cast Against Abstentions Broker Non-Votes 228,280,853 4,764,836 1,349,137 51,448,019
SEC 8-K Item 5.07
confidence 0.98
SEC evidence
b7362c0de00db2c46dccfff88df14ca5a69668da
SIRIUS XM HOLDINGS INC. shareholders approved Ratification of the Appointment of KPMG LLP as Our Independent Registered Public Accountants for 2026 at the 2026-05-28 meeting.
Item 4 – Ratification of the Appointment of KPMG LLP as Our Independent Registered Public Accountants for 2026 The holders of our common stock ratified the appointment of KPMG LLP as our independent registered public accountants for 2026. Votes Cast For Votes Cast Against Abstentions 281,049,339 2,379,515 2,413,991
SEC 8-K Item 5.07
confidence 0.98
SEC evidence
c35ed6697726b869c3cb77546a1f0807bd708a7a
SIRIUS XM HOLDINGS INC. shareholders approved Approval of Amendment No. 1 to the Sirius XM Holdings Inc. 2024 Long-Term Stock Incentive Plan at the 2026-05-28 meeting.
Item 3 – Approval of Amendment No. 1 to Sirius XM Holdings Inc. 2024 Long-Term Stock Incentive Plan The holders of our common stock approved Amendment No. 1 to the 2024 Plan. Votes Cast For Votes Cast Against Abstentions Broker Non-Votes 224,632,532 8,579,820 1,182,474 51,448,019
SEC 8-K Item 5.07
confidence 0.98
SEC evidence
Comparable filings
CRM
Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected
Salesforce, Inc.
June 1, 2026, 4:43 PM ET
other_material
Items 5.07, 5.02, 9.01
same fact type: shareholder_vote
same SEC item: 5.02, 5.07, 9.01
same event type: other_material
similar materiality
This filing
Election of Directors The holders of our common stock elected the persons listed below as Class I directors. Votes Cast For Votes Withheld Broker Non-Votes Eddy W. Hartenstein 229,472,971 4,921,855 51,448,019 Kristina M. Salen 231,643,217 2,751,609 51,448,019 Jennifer C. Witz 230,660,585 3,734,241 51,448,019 The holders of our common stock elected the persons listed below as Class II directors. Votes Cast For Votes Withheld Broker Non-Votes Evan D. Malone 230,881,893 3,512,933 51,448,019 Jonelle Procope 210,894,725 23,500,101 51,448,019 Anjali Sud 213,150,753 21,244,073 51,448,019
Comparable filing
Advisory vote to approve the fiscal 2026 compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 493,864,228 117,716,717 668,510 102,463,325
Filing page
SEC filing
BRANDYWINE OPERATING PARTNERSHIP, L.P.
Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP
BRANDYWINE OPERATING PARTNERSHIP, L.P.
June 1, 2026, 4:30 PM ET
other_material
Items 1.01, 2.03, 5.02, 5.07, 9.01
same fact type: shareholder_vote
same SEC item: 5.02, 5.07, 9.01
same event type: other_material
similar materiality
This filing
Election of Directors The holders of our common stock elected the persons listed below as Class I directors. Votes Cast For Votes Withheld Broker Non-Votes Eddy W. Hartenstein 229,472,971 4,921,855 51,448,019 Kristina M. Salen 231,643,217 2,751,609 51,448,019 Jennifer C. Witz 230,660,585 3,734,241 51,448,019 The holders of our common stock elected the persons listed below as Class II directors. Votes Cast For Votes Withheld Broker Non-Votes Evan D. Malone 230,881,893 3,512,933 51,448,019 Jonelle Procope 210,894,725 23,500,101 51,448,019 Anjali Sud 213,150,753 21,244,073 51,448,019
Comparable filing
PROPOSAL 2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for calendar year 2026. Votes For Votes Against Abstentions 134,853,955 7,100,190 646,621
Filing page
SEC filing
ESPR
Esperion shareholders approve 7M-share increase to 2022 equity incentive plan
Esperion Therapeutics, Inc.
June 1, 2026, 4:22 PM ET
other_material
Items 5.02, 5.07, 9.01
same fact type: shareholder_vote
same SEC item: 5.02, 5.07, 9.01
same event type: other_material
similar materiality
This filing
Election of Directors The holders of our common stock elected the persons listed below as Class I directors. Votes Cast For Votes Withheld Broker Non-Votes Eddy W. Hartenstein 229,472,971 4,921,855 51,448,019 Kristina M. Salen 231,643,217 2,751,609 51,448,019 Jennifer C. Witz 230,660,585 3,734,241 51,448,019 The holders of our common stock elected the persons listed below as Class II directors. Votes Cast For Votes Withheld Broker Non-Votes Evan D. Malone 230,881,893 3,512,933 51,448,019 Jonelle Procope 210,894,725 23,500,101 51,448,019 Anjali Sud 213,150,753 21,244,073 51,448,019
Comparable filing
The Company’s stockholders approved Proposal 3. The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes 167,083,447 8,765,273 1,360,136 —
Filing page
SEC filing
LUV
Southwest shareholders approve amended equity plan with 4.75M share increase; all directors elected
SOUTHWEST AIRLINES CO
May 20, 2024, 7:59 PM ET
other_material
Items 5.02, 5.07, 9.01
same fact type: shareholder_vote
same SEC item: 5.02, 5.07, 9.01
same event type: other_material
similar materiality
This filing
Election of Directors The holders of our common stock elected the persons listed below as Class I directors. Votes Cast For Votes Withheld Broker Non-Votes Eddy W. Hartenstein 229,472,971 4,921,855 51,448,019 Kristina M. Salen 231,643,217 2,751,609 51,448,019 Jennifer C. Witz 230,660,585 3,734,241 51,448,019 The holders of our common stock elected the persons listed below as Class II directors. Votes Cast For Votes Withheld Broker Non-Votes Evan D. Malone 230,881,893 3,512,933 51,448,019 Jonelle Procope 210,894,725 23,500,101 51,448,019 Anjali Sud 213,150,753 21,244,073 51,448,019
Comparable filing
3. Proposal 3 – Approval of the Southwest Airlines Co. Amended and Restated 2007 Equity Incentive Plan: VOTES FOR VOTES AGAINST ABSTENTIONS BROKER NON-VOTES 408,346,613 28,870,401 1,635,532 90,613,942
Filing page
SEC filing
Regulus Therapeutics Inc.
Regulus shareholders approve 2019 Equity Plan amendment adding 9.5M shares
Regulus Therapeutics Inc.
May 17, 2024, 7:59 PM ET
other_material
Items 5.02, 5.07, 9.01
same fact type: shareholder_vote
same SEC item: 5.02, 5.07, 9.01
same event type: other_material
similar materiality
This filing
Election of Directors The holders of our common stock elected the persons listed below as Class I directors. Votes Cast For Votes Withheld Broker Non-Votes Eddy W. Hartenstein 229,472,971 4,921,855 51,448,019 Kristina M. Salen 231,643,217 2,751,609 51,448,019 Jennifer C. Witz 230,660,585 3,734,241 51,448,019 The holders of our common stock elected the persons listed below as Class II directors. Votes Cast For Votes Withheld Broker Non-Votes Evan D. Malone 230,881,893 3,512,933 51,448,019 Jonelle Procope 210,894,725 23,500,101 51,448,019 Anjali Sud 213,150,753 21,244,073 51,448,019
Comparable filing
Proposal 5. The Company’s stockholders approved the Amended 2019 Plan which, among other things, increased the number of shares of our common stock authorized for issuance under the 2019 Plan by 9,500,000 shares and modified the calculation of the annual automatic share reserve increase to take into account shares of common stock issuable upon conversion or exercise of convertible preferred stock and prefunded warrants. Votes For Votes Against Abstentions Broker Non-Votes 32,563,555 5,916,084 29,301 3,688,130
Filing page
SEC filing
OSUR
OraSure shareholders approve 3M share increase in stock plan, charter amendment limiting officer liability
ORASURE TECHNOLOGIES INC
May 17, 2024, 7:59 PM ET
other_material
Items 5.02, 5.03, 5.07, 9.01
same fact type: shareholder_vote
same SEC item: 5.02, 5.07, 9.01
same event type: other_material
similar materiality
This filing
Election of Directors The holders of our common stock elected the persons listed below as Class I directors. Votes Cast For Votes Withheld Broker Non-Votes Eddy W. Hartenstein 229,472,971 4,921,855 51,448,019 Kristina M. Salen 231,643,217 2,751,609 51,448,019 Jennifer C. Witz 230,660,585 3,734,241 51,448,019 The holders of our common stock elected the persons listed below as Class II directors. Votes Cast For Votes Withheld Broker Non-Votes Evan D. Malone 230,881,893 3,512,933 51,448,019 Jonelle Procope 210,894,725 23,500,101 51,448,019 Anjali Sud 213,150,753 21,244,073 51,448,019
Comparable filing
ITEM 1 . Election of two Class III Directors for Terms Ending in 2027. NAME Votes For Votes Against Abstentions Broker Non-Votes Nancy J. Gagliano, M.D. 57,243,711 4,832,639 46,575 5,007,157 Lelio Marmora 57,332,773 4,732,865 57,287 5,007,157
Filing page
SEC filing
Nemaura Medical Inc.
Shareholders approve reverse stock split authorization at ratio of 1:10 to 1:150
Nemaura Medical Inc.
May 17, 2024, 7:59 PM ET
other_material
Items 5.07, 9.01
same fact type: shareholder_vote
same SEC item: 5.07, 9.01
same event type: other_material
similar materiality
This filing
Election of Directors The holders of our common stock elected the persons listed below as Class I directors. Votes Cast For Votes Withheld Broker Non-Votes Eddy W. Hartenstein 229,472,971 4,921,855 51,448,019 Kristina M. Salen 231,643,217 2,751,609 51,448,019 Jennifer C. Witz 230,660,585 3,734,241 51,448,019 The holders of our common stock elected the persons listed below as Class II directors. Votes Cast For Votes Withheld Broker Non-Votes Evan D. Malone 230,881,893 3,512,933 51,448,019 Jonelle Procope 210,894,725 23,500,101 51,448,019 Anjali Sud 213,150,753 21,244,073 51,448,019
Comparable filing
On May 9, 2024, the Shareholders of Nemaura Medical Inc. (the “Company”) approved by written consent to authorize amendments to the Articles of Incorporation of the Company (the “Articles”) to effect a reverse stock split of the common stock, par value $0.001 per share, of the Company (the “Common Stock”) ranging in ratio between 1-for-10 and 1-for-150, with one share of Common Stock being issued for a range of between each 10 and 150 shares of Common Stock issued and outstanding, with such final ratio to be determined by the Board following approval thereof by the shareholders of the Company, with any fractional shares of Common Stock resulting therefrom being rounded up to the nearest whole share of Common Stock (the “Reverse Split”), and to amend the Articles to effect the Reverse Split.
Filing page
SEC filing
INTEVAC INC
Stockholders approve share increases for ESPP and equity incentive plan at 2024 annual meeting
INTEVAC INC
May 17, 2024, 7:59 PM ET
other_material
Items 5.02, 5.07
same fact type: shareholder_vote
same SEC item: 5.02, 5.07
same event type: other_material
similar materiality
This filing
Election of Directors The holders of our common stock elected the persons listed below as Class I directors. Votes Cast For Votes Withheld Broker Non-Votes Eddy W. Hartenstein 229,472,971 4,921,855 51,448,019 Kristina M. Salen 231,643,217 2,751,609 51,448,019 Jennifer C. Witz 230,660,585 3,734,241 51,448,019 The holders of our common stock elected the persons listed below as Class II directors. Votes Cast For Votes Withheld Broker Non-Votes Evan D. Malone 230,881,893 3,512,933 51,448,019 Jonelle Procope 210,894,725 23,500,101 51,448,019 Anjali Sud 213,150,753 21,244,073 51,448,019
Comparable filing
Proposal 5: Advisory Approval of Named Executive Officer Compensation Intevac’s stockholders approved, on a non-binding, advisory basis, the compensation of Intevac’s named executive officers.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.